|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Operating expenses: | |||||
| Cost of Revenue | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest and other income (loss), net | |||||
| Interest and other income, net | |||||
| Income from equity method investment | |||||
| Transaction expenses related to merger | |||||
| Convertible note extinguishment loss | |||||
| Loss on common stock issuance in private placement | |||||
| Loss from change in fair value of warrants, earnout shares and contingent consideration | |||||
| Total other loss, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding, basic (in shares) | |||||
| Weighted-average common shares outstanding, diluted (in shares) | |||||
Loading...